Concepedia

Vera Buerger

VB

Statistics

Publications

12

Citations

813

H-Index

11

Active since

2006

Affiliations

Valneva (Austria)(Current)

Vienna Biocenter

Intercell (Austria)

University of Applied Sciences Burgenland

The University of Texas Medical Branch at Galveston

Vera Buerger is an author at Valneva (Austria) specializing in infectious diseases, immunology, and vaccination.

ORCID

Publications per year

2006–2025

12

Publications

12

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 223 citations · Full text

, , +17

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Christoph Klade, Heiner Wedemeyer, Thomas Berg et al. · Gastroenterology · 2008 · 153 citations

, , +16

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

Christa Firbas, Bernd Jilma, Erich Tauber et al. · Vaccine · 2006 · 140 citations

, , +16

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

Katrin Dubischar-Kastner, Susanne Eder, Vera Buerger et al. · Vaccine · 2010 · 65 citations

, , +16

Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine

Christa Firbas, Thomas Boehm, Vera Buerger et al. · Vaccine · 2010 · 57 citations

, , +14

1–5 of 12